Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism JAK inhibitors(Janus kinase inhibitors), NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), STAT inhibitors(STAT transcription factors inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H22Cl2N4O |
InChIKeyJEESDVDVWGRNFE-UHFFFAOYSA-N |
CAS Registry3031837-35-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | China | 02 Sep 2022 | |
Inflammatory Bowel Diseases | Preclinical | China | 02 Sep 2022 |